Graphene Oxide-Supported Ag Nanoplates as LSPR Tunable and Reproducible Substrates for SERS Applications with Optimized Sensitivity

Nanoparticles and nanohybrids with well-defined structures, along with tunable localized surface plasmon resonance (LSPR) properties and optimized sensitivity, are crucial and highly desired for surface-enhanced Raman spectroscopy (SERS) applications. In this article, we report on a very promising and flexible SERS platforms with a tunable LSPR response and sensitivity based on Ag nanoplates and graphene oxide (GO). The SERS detection sensitivity can be easily optimized and significantly improved by fine-tuning the LSPR band of the Ag nanoplate/GO substrates (to enhance the SERS response) during sample preparation. We applied the as-prepared SERS platform for sensitive SERS detection of 4-mercaptobenzoic acid and 4-aminothiophenol and found that the SERS signal varied markedly (by ∼10-15-fold) with the fine-tuning of the LSPR band. The SERS enhancement factor of the Ag nanoplate/GO complexes was more than 10(4) times larger than that obtained using spherical Ag nanoparticles. The as-prepared Ag nanoplate/GO platforms, because of their excellent stability and tunable LSPR properties, will find promising practical SERS applications.

Improved SERS Nanoparticles for Direct Detection of Circulating Tumor Cells in the Blood

The detection of circulating tumor cells (CTCs) in the blood of cancer patients is crucial for early cancer diagnosis, cancer prognosis, evaluation of the treatment effect of chemotherapy drugs, and choice of cancer treatment options. In this study, we propose new surface-enhanced Raman scattering (SERS) nanoparticles for the direct detection of CTCs in the blood. Under the optimized experimental conditions, our SERS nanoparticles exhibit satisfying performances for the direct detection of cancer cells in the rabbit blood. A good linear relationship is obtained between the SERS intensity and the concentration of cancer cells in the range of 5-500 cells/mL (R(2) = 0.9935), which demonstrates that the SERS nanoparticles can be used for the quantitative analysis of cancer cells in the blood and the limit of detection is 5 cells/mL, which is lowest compared with the reported values. The SERS nanoparticles also have an excellent specificity for the detection of cancer cells in the rabbit blood. The above results reinforce that our SERS nanoparticles can be used for the direct detection of CTCs in the blood with excellent specificity and high sensitivity.